Article
Posaconazole inhibits dengue virus replication by targeting oxysterol-binding protein
3 Jul 2018
Abstract excerpt
Dengue virus (DENV) is associated with an estimated 390 million infections per year, occurring across approximately 100 countries in tropical and sub-tropical regions. To date, there are no antiviral drugs or specific therapies to treat DENV infection. Posaconazole and itraconazole are potent antifungal drugs that inhibit ergosterol biosynthesis in fungal cells, but also target a number of human proteins. Here,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
